Proxy Votes Now

Home › Funds › Equitable › EQ/Common Stock Index Portfolio

EQ/Common Stock Index Portfolio proxy voting record 2025-2026

Fund family: Equitable · Filed by EQ ADVISORS TRUST (CIK 1027263) · SEC series S000010734

2023-20242024-20252025-2026

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 15,321 with, 417 against, 59 abstentions (not counted as with management); 10 items carried no recommendation. Shareholder proposals: 166 FOR, 251 AGAINST, 2 abstained, by the filing’s own vote-source field.

Compared with Equitable as a whole

The same two figures as Equitable’s manager page (393,894 ballot items across 72 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsEquitableItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)87.8%14,98592.5%339,726
Backed environmental and social shareholder proposals at US companies20.0%1659.6%3,486

Where this fund voted differently from most Equitable funds

Each ballot item this fund voted is set against the votes of the other Equitable funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Equitable funds on 1,127 items (7.3% of the 15,400 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Equitable fundsMgmtResult
Rackspace Technology, Inc.2026-06-18Approve an amendment to the Company's 2020 Equity Incentive Plan to increase the number of shares of common stock authorized to be issued under the plan.AgainstFOR — 5 of 5 Equitable fundsAgainstApproved, 92.2% support
Vaxcyte, Inc.2026-06-153 wordings Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Olivier Brandicourt, M.D.WithholdFOR — 7 of 8 Equitable fundsAgainstPassed (calculated), 87.5% support
Oracle Corporation2025-11-18Election of Directors: Charles W. MoormanWithholdFOR — 17 of 24 Equitable fundsAgainstElected, 97.8% support
Oracle Corporation2025-11-18Election of Directors: George H. ConradesWithholdFOR — 17 of 24 Equitable fundsAgainstElected, 92.3% support
Oracle Corporation2025-11-18Election of Directors: Jeffrey S. BergWithholdFOR — 17 of 24 Equitable fundsAgainstElected, 92.2% support
Oracle Corporation2025-11-18Election of Directors: Naomi O. SeligmanWithholdFOR — 17 of 24 Equitable fundsAgainstElected, 92.6% support
Oracle Corporation2025-11-18Election of Directors: Rona A. FairheadWithholdFOR — 17 of 24 Equitable fundsAgainstElected, 98.4% support
Meta Platforms, Inc.2026-05-27Election of Directors: Nancy KilleferWithholdFOR — 16 of 23 Equitable fundsAgainstElected, 97.3% support
Roblox Corporation2026-05-28Election of Class II Directors: David BaszuckiWithholdFOR — 6 of 7 Equitable fundsAgainstElected, 93.9% support
Praxis Precision Medicines, Inc.2026-06-10To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory NordenWithholdFOR — 8 of 10 Equitable fundsAgainstPassed (calculated), 98.8% support
Praxis Precision Medicines, Inc.2026-06-10To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William YoungWithholdFOR — 8 of 10 Equitable fundsAgainstPassed (calculated), 85.5% support
Cerence Inc.2026-02-12Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement.AgainstFOR — 6 of 7 Equitable fundsAgainstPassed (calculated), 77.2% support
ZimVie Inc.2025-10-10A proposal to adopt the Agreement and Plan of Merger, dated as of July 20, 2025 (the "merger agreement"), by and among ZimVie Inc. (the "Company"), Zamboni Parent Inc. ("Parent"), and Zamboni MergerCo Inc. ("MergerCo"), pursuant to which and subject to the terms and conditions thereof, MergerCo willAbstainFOR — 6 of 7 Equitable fundsAgainstApproved, 99.9% support
ZimVie Inc.2025-10-10A proposal to approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are insufficient votes at the special meeting to approve Proposal 1.AbstainFOR — 6 of 7 Equitable fundsAgainst—
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane SandersAgainstFOR — 14 of 20 Equitable fundsAgainstElected, 73.8% support
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. SpoonAgainstFOR — 14 of 20 Equitable fundsAgainstElected, 92.5% support
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. LamannaAgainstFOR — 14 of 20 Equitable fundsAgainstElected, 99.2% support
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MDAgainstFOR — 14 of 20 Equitable fundsAgainstElected, 90.6% support
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz DewanAgainstFOR — 14 of 20 Equitable fundsAgainstElected, 96.4% support
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda FillerAgainstFOR — 14 of 20 Equitable fundsAgainstElected, 81.4% support
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. RalesAgainstFOR — 14 of 20 Equitable fundsAgainstElected, 98.2% support
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. BlairAgainstFOR — 14 of 20 Equitable fundsAgainstElected, 98.8% support
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D.AgainstFOR — 14 of 20 Equitable fundsAgainstElected, 79.7% support
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. RalesAgainstFOR — 14 of 20 Equitable fundsAgainstElected, 97.2% support
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri L. ListAgainstFOR — 14 of 20 Equitable fundsAgainstElected, 77.7% support
Show the next 475
Items 26 to 500.
CompanyMeetingItemThis fundMost Equitable fundsMgmtResult
Oracle Corporation2025-11-18Election of Directors: Jeffrey O. HenleyWithholdFOR — 16 of 24 Equitable fundsAgainstElected, 92.0% support
Oracle Corporation2025-11-18Election of Directors: Michael J. BoskinWithholdFOR — 16 of 24 Equitable fundsAgainstElected, 91.3% support
Wells Fargo & Company2026-04-28Shareholder Shareholder Proposal - Energy Supply Ratio.ForAGAINST — 12 of 17 Equitable fundsAgainstFailed (calculated), 20.6% support
Dominion Energy, Inc.2026-05-05Shareholder Shareholder Proposal Regarding a Policy for an Independent ChairForAGAINST — 12 of 17 Equitable fundsAgainstNot approved, 24.5% support
Datadog, Inc.2026-06-15To elect four Class I directors, each to hold office until our Annual Meeting of Stockholders in 2029: Olivier PomelWithholdFOR — 13 of 19 Equitable fundsAgainstPassed (calculated), 98.1% support
NIKE, Inc.2025-09-09To approve executive compensation by an advisory vote.AgainstFOR — 13 of 19 Equitable fundsAgainstPassed (calculated), 93.6% support
Targa Resources Corp.2026-05-21To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Charles R. CrispAgainstFOR — 13 of 19 Equitable fundsAgainstElected, 96.4% support
Targa Resources Corp.2026-05-21To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Laura C. FultonAgainstFOR — 13 of 19 Equitable fundsAgainstElected, 87.2% support
Targa Resources Corp.2026-05-21To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Paul W. ChungAgainstFOR — 13 of 19 Equitable fundsAgainstElected, 94.0% support
Targa Resources Corp.2026-05-21To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: R. Keith TeagueAgainstFOR — 13 of 19 Equitable fundsAgainstElected, 96.9% support
Meta Platforms, Inc.2026-05-27Election of Directors: Charles SonghurstWithholdFOR — 15 of 23 Equitable fundsAgainstElected, 99.1% support
Meta Platforms, Inc.2026-05-27Election of Directors: John ArnoldWithholdFOR — 15 of 23 Equitable fundsAgainstElected, 99.0% support
Meta Platforms, Inc.2026-05-27Election of Directors: Patrick CollisonWithholdFOR — 15 of 23 Equitable fundsAgainstElected, 99.0% support
Cogent Biosciences, Inc.2026-06-09Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Arlene M. MorrisWithholdFOR — 7 of 9 Equitable fundsAgainstElected, 83.9% support
Cogent Biosciences, Inc.2026-06-09Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dr. Chris CainWithholdFOR — 7 of 9 Equitable fundsAgainstElected, 86.8% support
Cogent Biosciences, Inc.2026-06-09Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Todd ShegogWithholdFOR — 7 of 9 Equitable fundsAgainstElected, 86.7% support
Johnson & Johnson2026-04-23Election of Directors: Mark A. WeinbergerAgainstFOR — 12 of 18 Equitable fundsAgainstPassed (calculated), 96.4% support
Capital One Financial Corporation2026-05-08Advisory vote on our Named Executive Officer compensation ("Say on Pay").AgainstFOR — 11 of 16 Equitable fundsAgainstPassed (calculated), 83.5% support
AMETEK, Inc.2026-05-07Election of Directors for a term of three years: Anthony J. ContiAgainstFOR — 12 of 18 Equitable fundsAgainstElected, 89.8% support
AMETEK, Inc.2026-05-07Election of Directors for a term of three years: Gretchen W. McClainAgainstFOR — 12 of 18 Equitable fundsAgainstElected, 86.7% support
AMETEK, Inc.2026-05-07Election of Directors for a term of three years: Thomas A. AmatoAgainstFOR — 12 of 18 Equitable fundsAgainstElected, 93.8% support
The Estee Lauder Companies Inc.2025-11-13Election of five (5) Class II Directors: Richard F. ZanninoWithholdFOR — 12 of 18 Equitable fundsAgainstPassed (calculated), 99.0% support
Kodiak Sciences Inc.2026-06-02Elect three Class II directors nominated by our board and named in this proxy statement: Bassil I. Dahiyat, Ph.D.WithholdFOR — 5 of 6 Equitable fundsAgainstElected, 98.7% support
Kodiak Sciences Inc.2026-06-02Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. BancroftWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 78.7% support
Kodiak Sciences Inc.2026-06-02Elect three Class II directors nominated by our board and named in this proxy statement: Taiyin Yang, Ph.D.WithholdFOR — 5 of 6 Equitable fundsAgainstElected, 99.4% support
CRISPR Therapeutics AG2026-06-04Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027.AgainstFOR — 5 of 6 Equitable fundsAgainst—
CRISPR Therapeutics AG2026-06-04Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026.AgainstFOR — 5 of 6 Equitable fundsAgainst—
CRISPR Therapeutics AG2026-06-04Re-election of Douglas A. Treco, Ph.D.ForAGAINST — 5 of 6 Equitable fundsForElected, 91.1% support
Standex International Corporation2025-10-21To elect the following Directors: Class III - for a three-year term expiring in 2028: Thomas E. Chorman (Class III, 3 year term)AgainstFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 88.5% support
Replimune Group, Inc.2025-09-03Election of Directors: Christy OligerWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 92.4% support
Replimune Group, Inc.2025-09-03Election of Directors: Joseph SlatteryWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 91.3% support
Replimune Group, Inc.2025-09-03Election of Directors: Kapil DhingraWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 84.4% support
Replimune Group, Inc.2025-09-03Election of Directors: Philip Astley-SparkeWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 95.9% support
First Financial Corporation2026-04-15Election of Directors: Gregory L. GibsonWithholdFOR — 5 of 6 Equitable fundsAgainst—
First Financial Corporation2026-04-15Election of Directors: Mark J. BladeWithholdFOR — 5 of 6 Equitable fundsAgainst—
First Financial Corporation2026-04-15Election of Directors: Norman D. LoweryWithholdFOR — 5 of 6 Equitable fundsAgainst—
First Financial Corporation2026-04-15Election of Directors: Paul J. PiersonWithholdFOR — 5 of 6 Equitable fundsAgainst—
First Financial Corporation2026-04-15Election of Directors: Richard J. ShagleyWithholdFOR — 5 of 6 Equitable fundsAgainst—
Allogene Therapeutics, Inc.2026-06-18Election of Directors: Deborah MessemerWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 88.6% support
Allogene Therapeutics, Inc.2026-06-18Election of Directors: Owen Witte, M.D.WithholdFOR — 5 of 6 Equitable fundsAgainstElected, 82.9% support
Allogene Therapeutics, Inc.2026-06-18Election of Directors: Vicki Sato, Ph.D.WithholdFOR — 5 of 6 Equitable fundsAgainstElected, 88.6% support
Atea Pharmaceuticals, Inc.2026-06-18Election of Class III Directors: Barbara DuncanWithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 85.6% support
Atea Pharmaceuticals, Inc.2026-06-18Election of Class III Directors: Howard Berman, PhDWithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 87.1% support
Atea Pharmaceuticals, Inc.2026-06-18Election of Class III Directors: Jerome Adams, MD, MPHWithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 56.4% support
Alector, Inc.2026-06-17ELECTION OF DIRECTORS: Elizabeth Garofalo, M.D.WithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 98.5% support
Alector, Inc.2026-06-17ELECTION OF DIRECTORS: Errol De Souza, Ph.D.WithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 98.9% support
Alector, Inc.2026-06-17ELECTION OF DIRECTORS: Kristine Yaffe, M.D.WithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 74.8% support
Rocket Pharmaceuticals, Inc.2026-05-20The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Carsten BoessWithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 99.1% support
Rocket Pharmaceuticals, Inc.2026-05-20The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Fady Malik, M.D., Ph.D.WithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 99.2% support
Rocket Pharmaceuticals, Inc.2026-05-20The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Mikael Dolsten, M.D., Ph.D.WithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 94.0% support
Rocket Pharmaceuticals, Inc.2026-05-20The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Roderick Wong, M.D.WithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 99.1% support
Codexis, Inc.2026-06-17Election of the three Class I directors named in the Proxy Statement to hold office for a three-year term expiring at the 2029 Annual Meeting: Rahul Singhvi, Sc.D.WithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 98.3% support
Codexis, Inc.2026-06-17Election of the three Class I directors named in the Proxy Statement to hold office for a three-year term expiring at the 2029 Annual Meeting: Raymond De Vre, Ph.D.WithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 98.9% support
Codexis, Inc.2026-06-17Election of the three Class I directors named in the Proxy Statement to hold office for a three-year term expiring at the 2029 Annual Meeting: Stephen G. Dilly, M.B.B.S., Ph.D.WithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 87.2% support
Organogenesis Holdings Inc.2026-06-15Election of Directors: Jon GiacominWithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 76.0% support
Resources Connection, Inc.2025-10-16Election of Directors: Susan M. CollynsAgainstFOR — 5 of 6 Equitable fundsAgainstElected, 76.0% support
Angi Inc.2026-06-10Approval of the Amended and Restated Angi Inc. 2017 Stock and Annual Incentive Plan.AgainstFOR — 5 of 6 Equitable fundsAgainst—
Angi Inc.2026-06-10Election of Class II Directors: Glenn H. SchiffmanForWITHHOLD — 5 of 6 Equitable fundsFor—
Angi Inc.2026-06-10Election of Class II Directors: Sandra BuchananWithholdFOR — 5 of 6 Equitable fundsAgainst—
Alphabet Inc.2026-06-05Election of ten directors: Larry PageAgainstFOR — 15 of 24 Equitable fundsAgainstElected, 97.9% support
Alphabet Inc.2026-06-05Election of ten directors: R. Martin "Marty" ChavezAgainstFOR — 15 of 24 Equitable fundsAgainstElected, 99.0% support
Alphabet Inc.2026-06-05Election of ten directors: Roger W. Ferguson Jr.AgainstFOR — 15 of 24 Equitable fundsAgainstElected, 98.6% support
Alphabet Inc.2026-06-05Election of ten directors: Sergey BrinAgainstFOR — 15 of 24 Equitable fundsAgainstElected, 98.1% support
Alphabet Inc.2026-06-05Election of ten directors: Sundar PichaiAgainstFOR — 15 of 24 Equitable fundsAgainstElected, 98.9% support
Meta Platforms, Inc.2026-05-27Election of Directors: Robert M. KimmittWithholdFOR — 15 of 24 Equitable fundsAgainstElected, 97.1% support
Sempra2026-05-12Advisory approval of our executive compensation.AgainstFOR — 13 of 20 Equitable fundsAgainstPassed (calculated), 87.5% support
Illumina, Inc.2026-05-21To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement.AgainstFOR — 8 of 11 Equitable fundsAgainstPassed (calculated), 93.5% support
DoorDash, Inc.2026-06-10The election of the following director nominee(s): Alfred LinAgainstFOR — 10 of 15 Equitable fundsAgainstElected, 93.8% support
DoorDash, Inc.2026-06-10The election of the following director nominee(s): Stanley TangAgainstFOR — 10 of 15 Equitable fundsAgainstElected, 94.0% support
Axon Enterprise, Inc.2026-05-28Election of nine directors of the Company named in the proxy statement: Caitlin KalinowskiAgainstFOR — 10 of 15 Equitable fundsAgainstElected, 98.5% support
Axon Enterprise, Inc.2026-05-28Election of nine directors of the Company named in the proxy statement: Graham SmithAgainstFOR — 10 of 15 Equitable fundsAgainstElected, 97.5% support
Axon Enterprise, Inc.2026-05-28Election of nine directors of the Company named in the proxy statement: Michael GarnreiterAgainstFOR — 10 of 15 Equitable fundsAgainstElected, 91.6% support
Lennar Corporation2026-04-08Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Amy BanseAgainstFOR — 10 of 15 Equitable fundsAgainstElected, 96.6% support
Lennar Corporation2026-04-08Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Armando OliveraAgainstFOR — 10 of 15 Equitable fundsAgainstElected, 97.5% support
Lennar Corporation2026-04-08Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Dacona SmithAgainstFOR — 10 of 15 Equitable fundsAgainstElected, 98.2% support
Lennar Corporation2026-04-08Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Jeffrey SonnenfeldAgainstFOR — 10 of 15 Equitable fundsAgainstElected, 84.2% support
Lennar Corporation2026-04-08Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Serena WolfeAgainstFOR — 10 of 15 Equitable fundsAgainstElected, 99.3% support
Lennar Corporation2026-04-08Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Sherrill W. HudsonAgainstFOR — 10 of 15 Equitable fundsAgainstElected, 94.3% support
Lennar Corporation2026-04-08Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Stuart MillerAgainstFOR — 10 of 15 Equitable fundsAgainstElected, 89.5% support
Lennar Corporation2026-04-08Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Teri P. McClureAgainstFOR — 10 of 15 Equitable fundsAgainstElected, 95.6% support
Lennar Corporation2026-04-08Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Theron (Tig) GilliamAgainstFOR — 10 of 15 Equitable fundsAgainstElected, 96.9% support
Alphabet Inc.2026-06-05Shareholder Shareholder proposal regarding an enhanced disclosure on climate goalsForAGAINST — 15 of 25 Equitable fundsAgainstNot approved, 7.4% support
Alphabet Inc.2026-06-05Election of ten directors: K. Ram ShriramAgainstFOR — 15 of 25 Equitable fundsAgainstElected, 95.2% support
Palo Alto Networks, Inc.2025-12-09Election of Class II Directors: John M. DonovanAgainstFOR — 12 of 19 Equitable fundsAgainstElected, 78.9% support
Thermo Fisher Scientific Inc.2026-05-20Election of Directors: Dion J. WeislerAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 89.5% support
Prologis, Inc.2026-04-28Advisory Vote to Approve the Company's Executive Compensation for 2025.AgainstFOR — 11 of 17 Equitable fundsAgainstPassed (calculated), 58.3% support
Prologis, Inc.2026-04-28Election of Directors: George L. FotiadesAgainstFOR — 11 of 17 Equitable fundsAgainstPassed (calculated), 87.8% support
Phillips 662026-05-13Election of four Class III Directors named in this Proxy Statement to hold office until the 2029 Annual Meeting: Gregory J. HayesAgainstFOR — 13 of 21 Equitable fundsAgainstPassed (calculated), 91.2% support
Regeneron Pharmaceuticals, Inc.2026-06-12Election of Directors: Craig B. Thompson, M.D.AgainstFOR — 11 of 17 Equitable fundsAgainstElected, 79.3% support
Regeneron Pharmaceuticals, Inc.2026-06-12Election of Directors: David P. Schenkein, M.D.AgainstFOR — 11 of 17 Equitable fundsAgainstElected, 96.0% support
Regeneron Pharmaceuticals, Inc.2026-06-12Election of Directors: Huda Y. Zoghbi, M.D.AgainstFOR — 11 of 17 Equitable fundsAgainstElected, 97.4% support
Regeneron Pharmaceuticals, Inc.2026-06-12Election of Directors: Joseph L. Goldstein, M.D.AgainstFOR — 11 of 17 Equitable fundsAgainstElected, 70.1% support
Datadog, Inc.2026-06-15To elect four Class I directors, each to hold office until our Annual Meeting of Stockholders in 2029: Dev IttycheriaWithholdFOR — 12 of 19 Equitable fundsAgainstElected, 88.8% support
Datadog, Inc.2026-06-15To elect four Class I directors, each to hold office until our Annual Meeting of Stockholders in 2029: Shardul ShahWithholdFOR — 12 of 19 Equitable fundsAgainstElected, 83.8% support
Workday, Inc.2026-06-16Election of Class II Directors: Mark J. HawkinsAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 93.4% support
Workday, Inc.2026-06-16Election of Class II Directors: Rhonda J. MorrisAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 99.3% support
Baker Hughes Company2026-05-19The Election of Directors: Cynthia B. CarrollAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 95.5% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Carl VogelAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 99.8% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Chad HollingsworthAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 94.9% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: James IovineAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 98.4% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: James S. KahanAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 98.8% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Jeffrey T. HinsonAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 98.6% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Latriece WatkinsAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 98.4% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Ping FuAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 99.6% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Randall T. MaysAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 97.0% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Richard A. GrenellAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 99.8% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Richard A. PaulAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 99.7% support
Live Nation Entertainment, Inc.2026-06-11To hold an advisory vote on the company's executive compensation;AgainstFOR — 11 of 17 Equitable fundsAgainstPassed (calculated), 86.8% support
The Hartford Insurance Group, Inc.2026-05-20Shareholder Shareholder proposal that the Company adopt written consent rights for shareholdersForAGAINST — 11 of 17 Equitable fundsAgainstNot approved, 45.2% support
SBA Communications Corporation2026-05-22Election of Directors: Amy E. WilsonAgainstFOR — 11 of 17 Equitable fundsAgainstPassed (calculated), 92.4% support
SBA Communications Corporation2026-05-22Election of Directors: Laurie BowenAgainstFOR — 11 of 17 Equitable fundsAgainstPassed (calculated), 88.6% support
SBA Communications Corporation2026-05-22Election of Directors: Steven E. BernsteinAgainstFOR — 11 of 17 Equitable fundsAgainstPassed (calculated), 94.3% support
Tractor Supply Company2026-05-14To approve, on a non-binding, advisory basis, the compensation of the named executive officers of the Company (Say on Pay)AgainstFOR — 12 of 19 Equitable fundsAgainstApproved, 86.0% support
Revvity, Inc.2026-04-28Shareholder To approve the shareholder proposal regarding Executives to Retain Significant Stock.ForAGAINST — 11 of 17 Equitable fundsAgainstFailed (calculated), 23.1% support
IDEX Corporation2026-05-06Election of four directors named in the proxy statement as follows: Alejandro Quiroz CentenoAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 98.8% support
IDEX Corporation2026-05-06Election of four directors named in the proxy statement as follows: Carl R. ChristensonAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 95.9% support
IDEX Corporation2026-05-06Election of four directors named in the proxy statement as follows: Katrina L. HelmkampAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 97.7% support
IDEX Corporation2026-05-06Election of four directors named in the proxy statement as follows: Mark A. BeckAgainstFOR — 11 of 17 Equitable fundsAgainstPassed (calculated), 93.5% support
Red Rock Resorts, Inc.2026-06-04Advisory vote to approve the compensation of our named executive officers.AgainstFOR — 6 of 8 Equitable fundsAgainst—
PotlatchDeltic Corporation2026-01-27The PotlatchDeltic adjournment proposal: A proposal to adjourn the special meeting from time to time, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the special meeting to approve the PotlatchDeltic merger agreement proposal.AbstainFOR — 6 of 8 Equitable fundsAgainst—
PotlatchDeltic Corporation2026-01-27The PotlatchDeltic merger agreement proposal: A proposal to adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "merger agreement"), dated as of October 13, 2025, by and among PotlatchDeltic Corporation ("PotlatchDeltic"), Rayonier Inc. ("Rayonier"), and Redwood MergeAbstainFOR — 6 of 8 Equitable fundsAgainstApproved, 99.9% support
Alphabet Inc.2026-06-05Shareholder Shareholder proposal regarding a report on AI-generated misinformationForAGAINST or ABSTAIN — 14 of 24 Equitable fundsAgainstNot approved, 9.3% support
Alphabet Inc.2026-06-05Election of ten directors: Frances H. ArnoldAgainstFOR — 14 of 24 Equitable fundsAgainstElected, 90.1% support
Tesla, Inc.2025-11-06A Tesla proposal for approval of the A&R 2019 Equity Incentive Plan.AgainstFOR — 13 of 22 Equitable fundsAgainstApproved, 79.1% support
Cisco Systems, Inc.2025-12-16Election of Directors: Daniel H. SchulmanAgainstFOR — 11 of 18 Equitable fundsAgainstPassed (calculated), 90.6% support
NextEra Energy, Inc.2026-05-21Approval, by non-binding advisory vote, of NextEra Energy's compensation of its named executive officers as disclosed in the proxy statement.AgainstFOR — 11 of 18 Equitable fundsAgainstApproved, 88.2% support
Salesforce, Inc.2026-05-28Approval, on an advisory basis, of the fiscal 2026 compensation of our named executive officers.AgainstFOR — 11 of 18 Equitable fundsAgainstPassed (calculated), 80.8% support
BlackRock, Inc.2026-05-20Approval, in a non-binding advisory vote, of the compensation for named executive officers.AgainstFOR — 9 of 14 Equitable fundsAgainstPassed (calculated), 65.0% support
The Charles Schwab Corporation2026-05-21Election of directors for three-year terms: Frank C. HerringerAgainstFOR — 13 of 22 Equitable fundsAgainstElected, 84.3% support
Booking Holdings Inc.2026-06-02Shareholder Non-binding stockholder vote on a proposal to avoid brand damage due to corporate political spending.ForAGAINST — 12 of 20 Equitable fundsAgainstNot approved, 35.2% support
AppLovin Corporation2026-06-03Election of Directors: EDUARDO VIVASWithholdFOR — 10 of 16 Equitable fundsAgainstPassed (calculated), 95.6% support
Moderna, Inc.2026-05-06To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: AbAgainstFOR — 10 of 16 Equitable fundsAgainstElected, 98.5% support
Adobe Inc.2026-04-15Election of the eleven (11) Directors proposed in the accompanying Proxy Statement to serve for a one-year term: Frank CalderoniAgainstFOR — 10 of 16 Equitable fundsAgainstPassed (calculated), 88.6% support
The Cigna Group2026-04-22Shareholder Shareholder Proposal - Shareholder Right to Act by Written ConsentForAGAINST — 11 of 18 Equitable fundsAgainstFailed (calculated), 47.9% support
Carvana Co.2026-05-05Shareholder To vote upon one stockholder proposal, as described in the Proxy Statement.ForAGAINST — 10 of 16 Equitable fundsAgainstNot approved, 3.9% support
DoorDash, Inc.2026-06-10The election of the following director nominee(s): Shona L. BrownAgainstFOR — 10 of 16 Equitable fundsAgainstElected, 89.8% support
Hewlett Packard Enterprise Company2026-04-01Advisory vote to approve the Hewlett Packard Enterprise Company's executive compensationAgainstFOR — 11 of 18 Equitable fundsAgainstPassed (calculated), 73.7% support
Workday, Inc.2026-06-16Election of Class II Directors: George J. Still, Jr.AgainstFOR — 11 of 18 Equitable fundsAgainstElected, 97.0% support
Zoetis Inc.2026-05-20Shareholder Shareholder proposal to permit shareholder action by written consent.ForAGAINST — 12 of 20 Equitable fundsAgainst—
Dollar General Corporation2026-05-28Shareholder To vote on a shareholder proposal asking the Board to take the steps necessary to reduce the minimum ownership percentage required to call a special shareholders' meeting from 25% to 10%.ForAGAINST — 10 of 16 Equitable fundsAgainstNot approved, 42.4% support
Corpay, Inc.2026-05-07Shareholder Shareholder proposal regarding an independent Board Chair requirement, if properly presented at the meeting.ForAGAINST — 10 of 16 Equitable fundsAgainstFailed (calculated), 30.0% support
Ralph Lauren Corporation2025-07-31Approval, on an advisory basis, of the compensation of our named executive officers and our compensation philosophy, policies and practices as described in the accompanying Proxy Statement.AgainstFOR — 10 of 16 Equitable fundsAgainstPassed (calculated), 99.2% support
Ralph Lauren Corporation2025-07-31Election of three (3) Class A Directors. Nominees as Class A Directors: Linda FindleyWithholdFOR — 10 of 16 Equitable fundsAgainstPassed (calculated), 96.5% support
KeyCorp2026-05-14Advisory approval of executive compensation.AgainstFOR — 10 of 16 Equitable fundsAgainstPassed (calculated), 92.4% support
Masco Corporation2026-05-08Shareholder Consideration of stockholder proposal on shareholder right to call a special meeting.ForAGAINST — 10 of 16 Equitable fundsAgainst—
Trimble Inc.2026-05-26Election of Directors: Borje EkholmWithholdFOR — 10 of 16 Equitable fundsAgainstElected, 94.0% support
Trimble Inc.2026-05-26Election of Directors: Johan WiberghWithholdFOR — 10 of 16 Equitable fundsAgainstElected, 95.5% support
Trimble Inc.2026-05-26Election of Directors: Ronald S. NersesianWithholdFOR — 10 of 16 Equitable fundsAgainstElected, 98.4% support
FactSet Research Systems Inc.2025-12-18To approve the FactSet Research Systems Inc. 2025 Omnibus Incentive Plan.AgainstFOR — 12 of 20 Equitable fundsAgainst—
FactSet Research Systems Inc.2025-12-18To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual MeetiAgainstFOR — 12 of 20 Equitable fundsAgainstElected, 94.1% support
FactSet Research Systems Inc.2025-12-18To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual MeetiAgainstFOR — 12 of 20 Equitable fundsAgainstElected, 98.2% support
FactSet Research Systems Inc.2025-12-18To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual MeetiAgainstFOR — 12 of 20 Equitable fundsAgainstElected, 98.2% support
FactSet Research Systems Inc.2025-12-18To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual MeetiAgainstFOR — 12 of 20 Equitable fundsAgainstElected, 98.1% support
Lennox International Inc.2026-05-21To elect three Class I directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Karen H. QuintosAgainstFOR — 10 of 16 Equitable fundsAgainstPassed (calculated), 93.2% support
Align Technology, Inc.2026-05-20Advisory Vote to Approve the Compensation of our Named Executive OfficersAgainstFOR — 10 of 16 Equitable fundsAgainstPassed (calculated), 89.4% support
Align Technology, Inc.2026-05-20Ratification of Special Meeting Provision in our BylawsAgainstFOR — 10 of 16 Equitable fundsAgainstPassed (calculated), 73.7% support
The AES Corporation2026-04-29Shareholder If properly presented, to vote on a non-binding stockholder proposal regarding stockholder ability to call a special meeting.ForAGAINST — 10 of 16 Equitable fundsAgainstFailed (calculated), 34.8% support
A. O. Smith Corporation2026-04-13Election of directors: Lois M. MartinWithholdFOR — 10 of 16 Equitable fundsAgainstPassed (calculated), 90.8% support
Krystal Biotech, Inc.2026-05-15Election of Class III Directors: Christopher MasonWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 84.0% support
Krystal Biotech, Inc.2026-05-15Election of Class III Directors: Krish S. KrishnanWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 88.5% support
GRAIL, Inc.2026-06-18Election of Class II Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successor has been duly elected and qualified: Steven MizellWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 77.6% support
UniFirst Corporation2026-06-11To adjourn the special meeting of UniFirst shareholders to a later date or dates, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment, there are not sufficient votes at the time of the UniFirst special meeting to approve the UniFirst merger proposal oAbstainFOR — 4 of 5 Equitable fundsAgainst—
Cathay General Bancorp2026-05-184 wordings Election of Class III Directors, to be elected for the term ending 2029: Nelson ChungAgainstFOR — 4 of 5 Equitable fundsAgainstElected, 92.7% support
Provident Financial Services, Inc.2026-05-21The election as directors of all nominees listed below (except as marked to the contrary on the right), each for a three-year term: Brian A. GragnolatiWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 97.9% support
Provident Financial Services, Inc.2026-05-21The election as directors of all nominees listed below (except as marked to the contrary on the right), each for a three-year term: Edward J. LeppertWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 95.9% support
Provident Financial Services, Inc.2026-05-21The election as directors of all nominees listed below (except as marked to the contrary on the right), each for a three-year term: Nadine LeslieWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 97.9% support
Provident Financial Services, Inc.2026-05-21The election as directors of all nominees listed below (except as marked to the contrary on the right), each for a three-year term: Thomas J. SharaWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 97.5% support
Surgery Partners, Inc.2026-06-05Election of Class II Directors: Brent TurnerWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 96.9% support
Surgery Partners, Inc.2026-06-05Election of Class II Directors: Devin O'ReillyWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 79.2% support
Surgery Partners, Inc.2026-06-05Election of Class II Directors: Laura L. Forese, M.D.WithholdFOR — 4 of 5 Equitable fundsAgainstElected, 80.2% support
IDEAYA Biosciences, Inc.2026-06-16To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Catherine J. Mackey, Ph.D.WithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 96.3% support
IDEAYA Biosciences, Inc.2026-06-16To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: M. Garret Hampton, Ph.D.WithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 77.7% support
IDEAYA Biosciences, Inc.2026-06-16To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Yujiro S. HataWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 96.6% support
ArcBest Corporation2026-04-24Shareholder A shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting.ForAGAINST — 4 of 5 Equitable fundsAgainst—
Xencor, Inc.2026-06-16Approval of the amendment to the Company's Amended and Restated 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 4,000,000 shares; andAgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 82.0% support
Neogen Corporation2025-10-23To Approve, On An Advisory Basis, The Compensation of Named Executive Officers.AgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 90.4% support
Peloton Interactive, Inc.2025-12-09Election of Directors: Karen BooneWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 98.1% support
Peloton Interactive, Inc.2025-12-09Election of Directors: Tara ComonteWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 99.1% support
Maravai Lifesciences Holdings, Inc.2026-05-26To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers.AgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 98.8% support
Maravai Lifesciences Holdings, Inc.2026-05-26To elect three nominees to the Board of Directors (3-year term expiring in 2029): Gregory T. LucierWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 88.5% support
Maravai Lifesciences Holdings, Inc.2026-05-26To elect three nominees to the Board of Directors (3-year term expiring in 2029): Luke MarkerWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 89.9% support
Omnicell, Inc.2026-05-19Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Eileen J. VoynickWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 93.0% support
Omnicell, Inc.2026-05-19Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Joanne B. BauerWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 89.6% support
Omnicell, Inc.2026-05-19Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Robin G. SeimWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 90.9% support
Diversified Healthcare Trust2026-06-106 wordings Election of Trustees. Nominees (for Independent Trustee): Alan FelderWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 98.0% support
Agios Pharmaceuticals, Inc.2026-06-18To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Rahul Ballal, Ph.D.WithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 87.1% support
Distribution Solutions Group, Inc.2026-05-14Election of seven directors to serve one year: Bianca A. RhodesWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 93.1% support
Distribution Solutions Group, Inc.2026-05-14Election of seven directors to serve one year: I. Steven EdelsonWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 93.9% support
Distribution Solutions Group, Inc.2026-05-14Election of seven directors to serve one year: Lee S. HillmanWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 94.0% support
Distribution Solutions Group, Inc.2026-05-14Election of seven directors to serve one year: M. Bradley WallaceWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 92.6% support
Distribution Solutions Group, Inc.2026-05-14Election of seven directors to serve one year: Mark F. MoonWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 90.3% support
Distribution Solutions Group, Inc.2026-05-14Election of seven directors to serve one year: Robert S. ZamarripaWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 94.1% support
Live Oak Bancshares, Inc.2026-05-19Election of Directors: David G. LuchtWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 86.0% support
Live Oak Bancshares, Inc.2026-05-19Election of Directors: James S. Mahan IIIWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 96.2% support
Live Oak Bancshares, Inc.2026-05-19Election of Directors: Miltom E. PettyWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 78.9% support
Live Oak Bancshares, Inc.2026-05-19Election of Directors: Neil L. UnderwoodWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 94.2% support
Live Oak Bancshares, Inc.2026-05-19Election of Directors: Patrick T. McHenryWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 99.0% support
Live Oak Bancshares, Inc.2026-05-19Election of Directors: Tonya W. BradfordWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 92.2% support
Live Oak Bancshares, Inc.2026-05-19Election of Directors: William H. CameronWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 74.7% support
Live Oak Bancshares, Inc.2026-05-19Election of Directors: William L. Williams IIIWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 94.4% support
Live Oak Bancshares, Inc.2026-05-19Election of Directors: Yousef A. ValineWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 78.3% support
Pacira Biosciences, Inc.2026-06-09Approval of our Amended and Restated 2011 Stock Incentive Plan.AgainstFOR — 4 of 5 Equitable fundsAgainstFailed (calculated), 43.5% support
Pacira Biosciences, Inc.2026-06-09Approval, on an advisory basis, of the compensation of our named executive officers.AgainstFOR — 4 of 5 Equitable fundsAgainst—
Phibro Animal Health Corporation2025-11-04Election of Class III Directors: Alejandro BernalWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 97.2% support
Tennant Company2026-04-29Elect three Class I directors to three-year terms: Carol S. EicherAgainstFOR — 4 of 5 Equitable fundsAgainstElected, 97.3% support
Tennant Company2026-04-29Elect three Class I directors to three-year terms: Donal L. MulliganAgainstFOR — 4 of 5 Equitable fundsAgainstElected, 97.2% support
Tennant Company2026-04-29Elect three Class I directors to three-year terms: Maria C. GreenAgainstFOR — 4 of 5 Equitable fundsAgainstElected, 96.2% support
Amphastar Pharmaceuticals, Inc.2026-06-01To elect three Class I directors to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: Jacob LiawatidewiAgainstFOR — 4 of 5 Equitable fundsAgainstElected, 65.5% support
PROCEPT BioRobotics Corporation2026-06-09Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.AgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 73.1% support
PROCEPT BioRobotics Corporation2026-06-093 wordings Election of Class II directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Antal DesaiWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 77.0% support
Castle Biosciences, Inc.2026-05-28To elect the three Class I director nominees listed below to hold office until the 2029 Annual Meeting of Stockholders: Ellen GoldbergWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 68.5% support
Castle Biosciences, Inc.2026-05-28To elect the three Class I director nominees listed below to hold office until the 2029 Annual Meeting of Stockholders: Miles D. HarrisonWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 69.1% support
Castle Biosciences, Inc.2026-05-28To elect the three Class I director nominees listed below to hold office until the 2029 Annual Meeting of Stockholders: Tiffany P. OlsonWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 63.7% support
Playtika Holding Corp.2026-06-11Election of Six Directors: Bing YuanWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 94.1% support
Playtika Holding Corp.2026-06-11Election of Six Directors: Dana GrossWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 99.3% support
Playtika Holding Corp.2026-06-11Election of Six Directors: Hong DuWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 98.6% support
Playtika Holding Corp.2026-06-11Election of Six Directors: Marc BeilinsonWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 94.6% support
Playtika Holding Corp.2026-06-11Election of Six Directors: Tian LinWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 99.6% support
Fox Factory Holding Corp.2026-05-08Election of Directors (term expires in 2029): Elizabeth A. FetterWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 87.6% support
Fox Factory Holding Corp.2026-05-08To approve, on an advisory basis, the resolution approving the compensation of Fox Factory Holding Corp.'s named executive officers.AgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 88.3% support
Hertz Global Holdings, Inc.2026-05-28Approval, on an advisory basis, of the compensation of our named executive officers.AgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 98.3% support
Kearny Financial Corp.2025-10-21The election of the five nominees listed, for the term indicated: Christopher Petermann, three-year termWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 88.4% support
Kearny Financial Corp.2025-10-21The election of the five nominees listed, for the term indicated: John F. McGovern, three-year termWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 86.2% support
Kearny Financial Corp.2025-10-21The election of the five nominees listed, for the term indicated: John J. Mazur, Jr., three-year termWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 82.9% support
Kearny Financial Corp.2025-10-21The election of the five nominees listed, for the term indicated: Melvina Wong-Zaza, two-year termWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 96.0% support
Kearny Financial Corp.2025-10-21The election of the five nominees listed, for the term indicated: Raymond E. Chandonnet, three-year termWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 95.1% support
NRC Health2026-06-23APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO CHANGE THE VOTING REQUIREMENT FOR STOCKHOLDER ACTION BY WRITTEN CONSENT IN LIEU OF A MEETING FROM UNANIMOUS TO THE VOTING POWER THAT WOULD BE REQUIRED TO GIVE EFFECT TO THE ACTION IF IT WERE APPROVED AT A MEETING, ALONG WITH CERTAIN CLAForAGAINST — 4 of 5 Equitable fundsForApproved, 94.8% support
NRC Health2026-06-23APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO REMOVE CERTAIN SUPERMAJORITY VOTING REQUIREMENTS IN ARTICLE 6 OF OUR CERTIFICATE OF INCORPORATION, ALONG WITH CERTAIN CLARIFYING, CONFORMING, AND MINISTERIAL CHANGES.ForAGAINST — 4 of 5 Equitable fundsForApproved, 95.1% support
NRC Health2026-06-23NON-BINDING, ADVISORY VOTE ON THE APPROVAL OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.AgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 85.5% support
Arvinas, Inc.2026-06-24Election of two Class II directors: Leslie V. Norwalk, Esq.WithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 75.8% support
Prothena Corporation plc2026-05-14To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Dennis J. SelkoeAgainstFOR — 4 of 5 Equitable fundsAgainstElected, 72.8% support
Prothena Corporation plc2026-05-14To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Shane M. CookeAgainstFOR — 4 of 5 Equitable fundsAgainstElected, 65.6% support
Editas Medicine, Inc.2026-06-17Election of two Class I Directors, each to serve until the 2029 annual meeting of stockholders: Elliott Levy, M.D.WithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 94.0% support
Editas Medicine, Inc.2026-06-17To approve, on an advisory basis, the compensation paid to the Company's named executive officers.AgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 83.9% support
ChargePoint Holdings, Inc.2025-07-084 wordings Election of Class II directors: Mitesh DhruvWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 92.2% support
ChargePoint Holdings, Inc.2025-07-08To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement;AgainstFOR — 4 of 5 Equitable fundsAgainst—
MBIA Inc.2026-05-05Election of Directors: Janice L. Innis-ThompsonAgainstFOR — 4 of 5 Equitable fundsAgainst—
MBIA Inc.2026-05-05Election of Directors: Richard C. VaughanAgainstFOR — 4 of 5 Equitable fundsAgainst—
MBIA Inc.2026-05-05Election of Directors: Steven J. GilbertAgainstFOR — 4 of 5 Equitable fundsAgainst—
MBIA Inc.2026-05-05Election of Directors: Theodore ShastaAgainstFOR — 4 of 5 Equitable fundsAgainst—
MBIA Inc.2026-05-05Election of Directors: William C. FallonAgainstFOR — 4 of 5 Equitable fundsAgainst—
MBIA Inc.2026-05-05To approve, on an advisory basis, executive compensation.AgainstFOR — 4 of 5 Equitable fundsAgainst—
Fate Therapeutics, Inc.2026-06-12Election of Class I Directors: Karin Jooss, Ph.D.WithholdFOR — 4 of 5 Equitable fundsAgainstElected, 97.7% support
Fate Therapeutics, Inc.2026-06-12Election of Class I Directors: Robert S. Epstein, M.D., M.S.WithholdFOR — 4 of 5 Equitable fundsAgainstElected, 97.2% support
Fate Therapeutics, Inc.2026-06-12To approve a proposal to amend and restate the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder.AgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 76.5% support
SITE Centers Corp.2026-05-13Election of Directors: David R. LukesAgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 96.3% support
Inogen, Inc.2026-06-05To approve the Inogen, Inc. Amended and Restated 2023 Equity Incentive Plan.AgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 89.0% support
Nkarta, Inc.2026-06-10Election of two directors to serve until the company's 2029 annual meeting of stockholders and until their respective successors are duly elected and qualified: Zachary Scheiner, Ph.D.WithholdFOR — 4 of 5 Equitable fundsAgainstElected, 79.7% support
Cable One, Inc.2026-05-14Election of Directors: Katharine B. WeymouthAgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 96.7% support
Select Medical Holdings Corporation2026-04-23Shareholder Non-Binding Advisory Vote on a Stockholder Proposal to provide stockholders the right to call a special meeting of stockholders at a 10% ownership threshold, if properly presented at the meeting.ForAGAINST — 4 of 5 Equitable fundsAgainstFailed (calculated), 20.0% support
Avanos Medical, Inc.2026-04-21Advisory vote to approve named executive officer compensation.AgainstFOR — 4 of 5 Equitable fundsAgainst—
Brookfield Business Corporation2026-01-13Approve BBUC Arrangement ResolutionAgainstFOR — 4 of 5 Equitable fundsAgainst—
Brookfield Business Corporation2026-06-18Elect Director Cyrus MadonWithholdFOR — 4 of 5 Equitable fundsAgainst—
Brookfield Business Corporation2026-06-18Elect Director David CourtWithholdFOR — 4 of 5 Equitable fundsAgainst—
Brookfield Business Corporation2026-06-18Elect Director Jeffrey BlidnerWithholdFOR — 4 of 5 Equitable fundsAgainst—
Brookfield Business Corporation2026-06-18Elect Director Lori PearsonWithholdFOR — 4 of 5 Equitable fundsAgainst—
Brookfield Business Corporation2026-06-18Elect Director Patricia ZuccottiWithholdFOR — 4 of 5 Equitable fundsAgainst—
Brookfield Business Corporation2026-06-18Elect Director Stephen GirskyWithholdFOR — 4 of 5 Equitable fundsAgainst—
DigitalBridge Group, Inc.2026-05-28To approve, on a non-binding, advisory basis, named executive officer compensationAgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 60.1% support
Enhabit, Inc.2026-05-12Approval, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Enhabit's named executive officers that is based on or otherwise relates to the Merger.AgainstFOR — 4 of 5 Equitable fundsAgainst—
Hillenbrand, Inc.2026-01-08Proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Hillenbrand, Inc.'s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement (the "Compensation PropoAgainstFOR — 4 of 5 Equitable fundsAgainst—
InnovAge Holding Corp.2025-12-04Election of Class II Directors: Richard ZoreticWithholdFOR — 4 of 5 Equitable fundsAgainst—
InnovAge Holding Corp.2025-12-04Election of Class II Directors: Teresa SparksWithholdFOR — 4 of 5 Equitable fundsAgainst—
Premier, Inc.2025-11-21A proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the transactions contemplated by the merger agreement, including consummation of the merger (the "advisory compensation proAgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 77.7% support
Sana Biotechnology, Inc.2026-06-04To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Robert NelsenWithholdFOR — 4 of 5 Equitable fundsAgainst—
Select Medical Holdings Corporation2026-04-23Non-Binding Advisory Vote on a Company Proposal to provide stockholders the right to call a special meeting of stockholders at a 25% ownership threshold.AgainstFOR — 4 of 5 Equitable fundsAgainst—
Select Medical Holdings Corporation2026-06-26To consider and vote on any proposal to adjourn the Special Meeting, from time to time, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting (the "Adjournment Proposal").AbstainFOR — 4 of 5 Equitable fundsAgainst—
Select Medical Holdings Corporation2026-06-26To consider and vote on the proposal to adopt the Agreement and Plan of Merger (as it may be amended, supplemented or modified from time to time, the "Merger Agreement"), dated as of March 2, 2026, by and among Stallion Intermediate Corporation ("Parent"), Stallion MergerSub Corporation ("Merger SubAbstainFOR — 4 of 5 Equitable fundsAgainst—
Y-mAbs Therapeutics, Inc.2025-07-11Election of Class I Director: David N. GillWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 61.3% support
Alphabet Inc.2026-06-05Shareholder Shareholder proposal regarding a report on AI data usage oversightForAGAINST — 14 of 25 Equitable fundsAgainstNot approved, 12.3% support
Alphabet Inc.2026-06-05Election of ten directors: L. John DoerrAgainstFOR — 14 of 25 Equitable fundsAgainstElected, 91.9% support
Meta Platforms, Inc.2026-05-27Election of Directors: Dana WhiteWithholdFOR — 13 of 23 Equitable fundsAgainstElected, 91.4% support
Meta Platforms, Inc.2026-05-27Election of Directors: Tony XuWithholdFOR — 13 of 23 Equitable fundsAgainstElected, 91.2% support
Advanced Micro Devices, Inc.2026-05-13Shareholder Stockholder proposal requesting changes to the stockholder right to call a special meeting.ForAGAINST — 12 of 21 Equitable fundsAgainstNot approved, 37.5% support
The Coca-Cola Company2026-04-29Shareholder Vote on a shareowner proposal requesting a report on the Company's plans to increase sustainability disclosureForAGAINST — 12 of 21 Equitable fundsAgainstFailed (calculated), 22.3% support
QUALCOMM Incorporated2026-03-17Shareholder Stockholder proposal entitled "Shareholder Ability to Call for a Special Meeting."ForAGAINST — 12 of 21 Equitable fundsAgainstNot approved, 42.2% support
International Business Machines Corporation2026-04-28Shareholder Stockholder Proposal Requesting a Right to Act by Written ConsentForAGAINST — 11 of 19 Equitable fundsAgainstFailed (calculated), 37.3% support
CrowdStrike Holdings, Inc.2026-06-17To elect CrowdStrike's nominees Johanna Flower and Denis J. O'Leary to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Johanna FlowerWithholdFOR — 9 of 15 Equitable fundsAgainstElected, 77.0% support
PepsiCo, Inc.2026-05-06Shareholder Shareholder Proposal - Report on Human Rights Oversight.ForAGAINST — 11 of 19 Equitable fundsAgainstNot approved, 16.5% support
Vertex Pharmaceuticals Incorporated2026-05-13Shareholder Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent.ForAGAINST — 10 of 17 Equitable fundsAgainstApproved, 57.0% support
AppLovin Corporation2026-06-03Election of Directors: BARBARA MESSINGWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 95.7% support
AppLovin Corporation2026-06-03Election of Directors: HERALD CHENWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 96.3% support
AppLovin Corporation2026-06-03Election of Directors: MARGARET GEORGIADISWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 92.1% support
AppLovin Corporation2026-06-03Election of Directors: MAYNARD WEBBWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 95.7% support
AppLovin Corporation2026-06-03Election of Directors: TODD MORGENFELDWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 99.2% support
Equinix, Inc.2026-05-13Election of directors to the Board of Directors (the "Board") to serve until the next Annual Meeting or until their successors have been duly elected and qualified: Sandra RiveraAgainstFOR — 11 of 19 Equitable fundsAgainstElected, 95.0% support
Adobe Inc.2026-04-15Approve, on an advisory basis, the compensation of our named executive officers.AgainstFOR — 10 of 17 Equitable fundsAgainstApproved, 50.7% support
Adobe Inc.2026-04-15Election of the eleven (11) Directors proposed in the accompanying Proxy Statement to serve for a one-year term: Amy BanseAgainstFOR — 10 of 17 Equitable fundsAgainstPassed (calculated), 85.5% support
United Parcel Service, Inc.2026-05-07To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: Angela HwangAgainstFOR — 9 of 15 Equitable fundsAgainstElected, 90.7% support
United Parcel Service, Inc.2026-05-07To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: Carol TomeAgainstFOR — 9 of 15 Equitable fundsAgainstElected, 85.6% support
United Parcel Service, Inc.2026-05-07To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: Christiana Smith ShiAgainstFOR — 9 of 15 Equitable fundsAgainstElected, 89.3% support
United Parcel Service, Inc.2026-05-07To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: Eva BorattoAgainstFOR — 9 of 15 Equitable fundsAgainstElected, 90.3% support
United Parcel Service, Inc.2026-05-07To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: Kevin ClarkAgainstFOR — 9 of 15 Equitable fundsAgainstElected, 91.1% support
United Parcel Service, Inc.2026-05-07To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: Rodney AdkinsAgainstFOR — 9 of 15 Equitable fundsAgainstElected, 90.0% support
United Parcel Service, Inc.2026-05-07To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: Wayne HewettAgainstFOR — 9 of 15 Equitable fundsAgainstElected, 90.8% support
KKR & Co. Inc.2026-05-21An amendment to the Existing Charter to grant the Board the sole authority to fill board vacancies and newly created directorships.AgainstFOR — 10 of 17 Equitable fundsAgainst—
Carvana Co.2026-05-05Election of Directors: Michael MarooneWithholdFOR — 9 of 15 Equitable fundsAgainstElected, 97.5% support
NIKE, Inc.2025-09-09Class B director nominees: To elect a Board of Directors for the ensuing year: John Rogers, Jr.WithholdFOR — 11 of 19 Equitable fundsAgainstPassed (calculated), 64.7% support
Delta Air Lines, Inc.2026-06-18Shareholder A shareholder proposal requesting the ability for shareholders to act by written consent.ForAGAINST — 9 of 15 Equitable fundsAgainstNot approved, 31.5% support
Monolithic Power Systems, Inc.2026-06-11Election of Directors: Victor K. LeeWithholdFOR — 10 of 17 Equitable fundsAgainstPassed (calculated), 89.8% support
eBay Inc.2026-06-17Shareholder Special stockholder meeting threshold, if properly presented.ForAGAINST — 10 of 17 Equitable fundsAgainstNot approved, 42.8% support
Ford Motor Company2026-05-14Election of Directors: Adriana CisnerosAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 98.2% support
Ford Motor Company2026-05-14Election of Directors: Alexandra Ford EnglishAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 97.7% support
Ford Motor Company2026-05-14Election of Directors: Beth E. MooneyAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 98.2% support
Ford Motor Company2026-05-14Election of Directors: Henry Ford IIIAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 97.7% support
Ford Motor Company2026-05-14Election of Directors: James D. Farley, Jr.AgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 97.6% support
Ford Motor Company2026-05-14Election of Directors: John B. VeihmeyerAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 97.8% support
Ford Motor Company2026-05-14Election of Directors: John C. MayAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 98.2% support
Ford Motor Company2026-05-14Election of Directors: John L. ThorntonAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 96.4% support
Ford Motor Company2026-05-14Election of Directors: John S. WeinbergAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 98.1% support
Ford Motor Company2026-05-14Election of Directors: Jon M. Huntsman, Jr.AgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 92.4% support
Ford Motor Company2026-05-14Election of Directors: Kimberly A. CasianoAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 96.6% support
Ford Motor Company2026-05-14Election of Directors: Lynn RadakovichAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 97.5% support
Ford Motor Company2026-05-14Election of Directors: William Clay Ford, Jr.AgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 91.1% support
Ford Motor Company2026-05-14Election of Directors: William E. KennardAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 81.8% support
Ford Motor Company2026-05-14Election of Directors: William W. Helman IVAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 97.0% support
Devon Energy Corporation2026-05-04Approve an amendment of Devon Energy Corporation's restated certificate of incorporation to increase the number of authorized shares of common stock from 1,000,000,000 to 2,000,000,000 (the "Authorized Share Charter Amendment Proposal", together with Stock Issuance Proposal, the "Devon Merger ProposAbstainFOR — 10 of 17 Equitable fundsAgainst—
Devon Energy Corporation2026-05-04Approve the adjournment of the Devon Energy Corporation special meeting of stockholders (the "Devon Special Meeting of Stockholders"), if necessary or appropriate, for the purpose of soliciting additional votes for the approval of the Devon Merger Proposals.AbstainFOR — 10 of 17 Equitable fundsAgainst—
Devon Energy Corporation2026-05-04Approve the issuance of shares of Devon Energy Corporation common stock to the holders of Coterra Energy Inc. common stock in connection with the merger, as contemplated by the Merger Agreement (the "Stock Issuance Proposal").AbstainFOR — 10 of 17 Equitable fundsAgainst—
Ares Management Corporation2026-06-08Election of Directors: Antoinette BushAgainstFOR — 10 of 17 Equitable fundsAgainstElected, 94.3% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Maverick CarterAgainstFOR — 10 of 17 Equitable fundsAgainstElected, 89.2% support
Prudential Financial, Inc.2026-05-12Shareholder Shareholder proposal regarding an Independent Board Chairman.ForAGAINST — 9 of 15 Equitable fundsAgainstNot approved, 30.5% support
Cboe Global Markets, Inc.2026-05-14Shareholder Stockholder proposal regarding shareholder right to act by written consent.ForAGAINST — 10 of 17 Equitable fundsAgainst—
Royalty Pharma plc2026-06-04Election of Directors: Vlad Coric, M.D.AgainstFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 88.8% support
Vulcan Materials Company2026-05-08Election of Directors: George A. WillisAgainstFOR — 9 of 15 Equitable fundsAgainstElected, 98.5% support
Vulcan Materials Company2026-05-08Election of Directors: James T. ProkopankoAgainstFOR — 9 of 15 Equitable fundsAgainstElected, 92.8% support
Vulcan Materials Company2026-05-08Election of Directors: Melissa H. AndersonAgainstFOR — 9 of 15 Equitable fundsAgainstElected, 99.2% support
Vulcan Materials Company2026-05-08Election of Directors: O.B. Grayson Hall, Jr.AgainstFOR — 9 of 15 Equitable fundsAgainstElected, 96.6% support
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Class I Directors of the Company for a term of three years and until their respective successors are duly elected and qualified or their earlier resignation or removal: Brian S. PosnerAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 96.6% support
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Class I Directors of the Company for a term of three years and until their respective successors are duly elected and qualified or their earlier resignation or removal: Eileen MalleschAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 97.8% support
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Class I Directors of the Company for a term of three years and until their respective successors are duly elected and qualified or their earlier resignation or removal: Francis EbongAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 88.7% support
United Airlines Holdings, Inc.2026-05-19Shareholder Advisory vote on stockholder proposal entitled "Shareholder Right to Act by Written Consent".ForAGAINST — 9 of 15 Equitable fundsAgainstNot approved, 39.6% support
Archer-Daniels-Midland Company2026-05-07Election of Directors: D.A. SandlerAgainstFOR — 10 of 17 Equitable fundsAgainstElected, 96.8% support
Archer-Daniels-Midland Company2026-05-07Election of Directors: D.R. McAtee IIAgainstFOR — 10 of 17 Equitable fundsAgainstElected, 99.0% support
Archer-Daniels-Midland Company2026-05-07Election of Directors: E. de BrabanderAgainstFOR — 10 of 17 Equitable fundsAgainstElected, 98.7% support
Archer-Daniels-Midland Company2026-05-07Election of Directors: J.C. Collins, Jr.AgainstFOR — 10 of 17 Equitable fundsAgainstElected, 99.0% support
Archer-Daniels-Midland Company2026-05-07Election of Directors: K.R. WestbrookAgainstFOR — 10 of 17 Equitable fundsAgainstElected, 96.1% support
Archer-Daniels-Midland Company2026-05-07Election of Directors: L.Z. SchlitzAgainstFOR — 10 of 17 Equitable fundsAgainstElected, 99.0% support
Archer-Daniels-Midland Company2026-05-07Election of Directors: M.S. BurkeAgainstFOR — 10 of 17 Equitable fundsAgainstElected, 97.8% support
Archer-Daniels-Midland Company2026-05-07Election of Directors: P.J. MooreAgainstFOR — 10 of 17 Equitable fundsAgainstElected, 95.8% support
Archer-Daniels-Midland Company2026-05-07Election of Directors: S.F. HarrisonAgainstFOR — 10 of 17 Equitable fundsAgainstElected, 98.5% support
Archer-Daniels-Midland Company2026-05-07Election of Directors: T. ColbertAgainstFOR — 10 of 17 Equitable fundsAgainstElected, 99.0% support
Archer-Daniels-Midland Company2026-05-07Election of Directors: T.K. CrewsAgainstFOR — 10 of 17 Equitable fundsAgainstElected, 98.0% support
Extra Space Storage Inc.2026-05-14Advisory vote on the compensation of the Company's named executive officers.AgainstFOR — 10 of 17 Equitable fundsAgainstPassed (calculated), 93.2% support
W. R. Berkley Corporation2026-06-03Election of Directors: Daniel L. MosleyAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 97.9% support
W. R. Berkley Corporation2026-06-03Election of Directors: Maria Luisa FerreAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 94.2% support
W. R. Berkley Corporation2026-06-03Election of Directors: Robert A. RusbuldtAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 98.2% support
W. R. Berkley Corporation2026-06-03Election of Directors: W. Robert Berkley, Jr.AgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 99.1% support
West Pharmaceutical Services, Inc.2026-05-04Shareholder Shareholder proposal regarding an independent Board Chair policy.ForAGAINST — 10 of 17 Equitable fundsAgainstNot approved, 46.4% support
Church & Dwight Co., Inc.2026-05-01Shareholder Stockholder Proposal - Permit Stockholder Action by Written Consent.ForAGAINST — 10 of 17 Equitable fundsAgainst—
Regions Financial Corporation2026-05-06Shareholder Shareholder Proposal Relating to Special Shareholder Meeting.ForAGAINST — 9 of 15 Equitable fundsAgainstNot approved, 43.9% support
Principal Financial Group, Inc.2026-05-19Election of Directors: Claudio N. MuruzabalAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 98.1% support
Principal Financial Group, Inc.2026-05-19Election of Directors: Jocelyn Carter-MillerAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 88.4% support
Principal Financial Group, Inc.2026-05-19Election of Directors: Jonathan S. AuerbachAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 99.1% support
Principal Financial Group, Inc.2026-05-19Election of Directors: Mary E. "Maliz" BeamsAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 99.0% support
Principal Financial Group, Inc.2026-05-19Election of Directors: Scott M. MillsAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 97.7% support
Tyson Foods, Inc.2026-02-05Election of Directors: Cheryl S. MillerAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 91.6% support
Tyson Foods, Inc.2026-02-05Election of Directors: Donnie KingAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 99.0% support
Tyson Foods, Inc.2026-02-05Election of Directors: Jeffrey K. SchomburgerAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 97.7% support
Tyson Foods, Inc.2026-02-05Election of Directors: John H. TysonAgainstFOR — 9 of 15 Equitable fundsAgainst—
Tyson Foods, Inc.2026-02-05Election of Directors: Kate B. QuinnAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 99.0% support
Tyson Foods, Inc.2026-02-05Election of Directors: Maria Claudia BorrasAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 94.3% support
Tyson Foods, Inc.2026-02-05Election of Directors: Maria N. MartinezAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 94.4% support
Tyson Foods, Inc.2026-02-05Election of Directors: Mike BeebeAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 94.2% support
Tyson Foods, Inc.2026-02-05To approve the amendment and restatement of the Tyson Foods, Inc. 2000 Stock Incentive Plan, a copy of which is attached to the Proxy Statement as Exhibit A.AgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 91.8% support
General Mills, Inc.2025-09-30Shareholder Shareholder Proposal - Disclosure of Regenerative Agriculture Practices Within Supply Chain.ForAGAINST — 10 of 17 Equitable fundsAgainstFailed (calculated), 28.1% support
Texas Pacific Land Corporation2025-11-06To elect the nine directors named in the Proxy Statement to serve until the 2026 Annual Meeting of Stockholders: Murray StahlAgainstFOR — 10 of 17 Equitable fundsAgainstPassed (calculated), 95.8% support
News Corporation2025-11-19Election of 6 Directors: Robert J. ThomsonAgainstFOR — 9 of 15 Equitable fundsAgainstElected, 99.2% support
Skyworks Solutions, Inc.2026-05-13Shareholder To approve a stockholder proposal regarding greenhouse gas emission reduction efforts report.ForAGAINST — 10 of 17 Equitable fundsAgainstNot approved, 16.6% support
Universal Health Services, Inc.2026-05-20Shareholder Stockholder proposal to adopt a policy requiring Universal Health Services, Inc. to publicly disclose its workforce diversity, if properly presented at the meeting.ForAGAINST — 9 of 15 Equitable fundsAgainst—
Align Technology, Inc.2026-05-20ELECTION OF DIRECTORS: Joseph LacobAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 95.6% support
Akamai Technologies, Inc.2026-05-13Shareholder To vote upon a shareholder proposal requiring the Company to provide a report on political spending.ForAGAINST — 10 of 17 Equitable fundsAgainstNot approved, 45.7% support
Insulet Corporation2026-05-20Election of Directors: Luciana BorioWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 93.5% support
Insulet Corporation2026-05-20Election of Directors: Michael R. MinogueWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 91.1% support
Insulet Corporation2026-05-20Election of Directors: Timothy C. StonesiferWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 95.4% support
Wynn Resorts, Limited2026-05-06To elect three Class III directors to serve until the 2029 Annual Meeting of Shareholders: Patricia MulroyAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 95.0% support
Wynn Resorts, Limited2026-05-06To elect three Class III directors to serve until the 2029 Annual Meeting of Shareholders: Philip G. SatreAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 99.0% support
Wynn Resorts, Limited2026-05-06To elect three Class III directors to serve until the 2029 Annual Meeting of Shareholders: Richard J. ByrneAgainstFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 93.9% support
PACS Group, Inc.2025-12-19To elect Taylor Leavitt and Jacqueline Millard as Class I directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Jacqueline MillardWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 97.0% support
PACS Group, Inc.2025-12-19To elect Taylor Leavitt and Jacqueline Millard as Class I directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Taylor LeavittWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 97.0% support
10x Genomics, Inc.2026-06-04Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatioAgainstFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 91.3% support
10x Genomics, Inc.2026-06-04Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatioAgainstFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 90.7% support
Compass, Inc.2026-05-14Election of Class II Directors: Allan LeinwandAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 97.0% support
Compass, Inc.2026-05-14Election of Class II Directors: Charles PhillipsAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 86.3% support
Compass, Inc.2026-05-14Election of Class II Directors: Pamela Thomas-GrahamAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 96.7% support
Ormat Technologies, Inc.2026-06-02To elect the eight director nominees listed below to the Board of Directors to hold office until the 2027 Annual Meeting of Stockholders: Michal MaromAgainstFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 94.7% support
New Jersey Resources Corporation2026-01-21Election of the following five Directors that were named in the Proxy Statement; each for a term expiring in 2029: Jane M. KennyWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 95.0% support
New Jersey Resources Corporation2026-01-21Election of the following five Directors that were named in the Proxy Statement; each for a term expiring in 2029: Sharon C. TaylorWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 97.1% support
Scholar Rock Holding Corporation2026-06-04To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Katie PengWithholdFOR — 5 of 7 Equitable fundsAgainstElected, 86.8% support
PTC Therapeutics, Inc.2026-06-02Election of Four Class I Directors: Jerome B. Zeldis, M.D., Ph.D.WithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 96.1% support
PTC Therapeutics, Inc.2026-06-02Election of Four Class I Directors: Stephanie S. Okey, M.S.WithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 94.8% support
Red Rock Resorts, Inc.2026-06-04Election of 5 director nominees: Frank J. Fertitta IIIWithholdFOR — 5 of 7 Equitable fundsAgainstElected, 98.8% support
Red Rock Resorts, Inc.2026-06-04Election of 5 director nominees: Lorenzo J. FertittaWithholdFOR — 5 of 7 Equitable fundsAgainstElected, 98.2% support
UFP Industries, Inc.2026-04-222 wordings Election of Directors To elect one director to serve until 2028: Mary Tuuk KurasAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 91.6% support
Flagstar Bank, N.A.2026-06-09An advisory vote to approve, on a non-binding basis, compensation of our named executive officers disclosed in the accompanying proxy statement.AgainstFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 81.2% support
AAR Corp.2025-09-16Election of four directors named in the proxy statement: Ellen M. LordAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 93.7% support
AAR Corp.2025-09-16Election of four directors named in the proxy statement: Jeffrey N. EdwardsAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 82.1% support
AAR Corp.2025-09-16Election of four directors named in the proxy statement: Marc J. WalfishAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 90.9% support
Lumen Technologies, Inc.2026-05-20Shareholder Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill.ForAGAINST — 5 of 7 Equitable fundsAgainstNot approved, 47.8% support
Wesbanco, Inc.2026-04-15To approve an advisory (non-binding) vote on compensation paid to Wesbanco's named executive officers in 2025.AgainstFOR — 5 of 7 Equitable fundsAgainstApproved, 64.6% support
Oklo Inc.2026-06-03Election of Directors: Richard W. KinzleyWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 83.3% support
Dyne Therapeutics, Inc.2026-06-05To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: David LubnerWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 91.5% support
Dyne Therapeutics, Inc.2026-06-05To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Jason RhodesWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 87.4% support
Bank of Hawaii Corporation2026-04-24Say on Pay - An advisory vote on executive compensation.AgainstFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 59.8% support
Stoke Therapeutics, Inc.2026-06-03Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Julie Anne SmithWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 86.9% support
Stoke Therapeutics, Inc.2026-06-03To approve, on an advisory basis, the compensation of the Company's named executive officers.AgainstFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 72.9% support
Yext, Inc.2026-06-10Approve the amended, restated and extended Yext, Inc. 2016 Equity Incentive Plan.AgainstFOR — 5 of 7 Equitable fundsAgainst—
Aeva Technologies, Inc.2026-06-18Election of Class II Directors: Stephen ZadeskyWithholdFOR — 5 of 7 Equitable fundsAgainst—
Coterra Energy Inc.2026-05-04To approve the adjournment of the Coterra Special Meeting, if necessary or appropriate, for the purpose of soliciting additional votes for the approval of the Coterra Merger Proposal (the "Coterra Adjournment Proposal").AbstainFOR — 10 of 17 Equitable fundsAgainst—
Electronic Arts Inc.2025-08-14Advisory vote to approve named executive officer compensation.AgainstFOR — 10 of 17 Equitable fundsAgainstPassed (calculated), 90.4% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Anton J. LevyWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 96.6% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Daniel E. SanchezWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 99.0% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: David M. ZaslavWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 96.6% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Debra L. LeeWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 68.2% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Fazal F. MerchantWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 96.6% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Geoffrey Y. YangWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 68.9% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Joseph M. LevinWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 77.8% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Kenneth W. LoweWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 68.8% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Paula A. PriceWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 98.7% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Richard W. FisherWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 68.6% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Samuel A. Di Piazza, Jr.WithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 98.2% support
Meta Platforms, Inc.2026-05-27Election of Directors: Andrew W. HoustonWithholdFOR — 13 of 24 Equitable fundsAgainstElected, 91.1% support
Marvell Technology, Inc.2026-06-25An advisory (non-binding) vote to approve compensation of our named executive officers.AgainstFOR — 7 of 11 Equitable fundsAgainstApproved, 55.9% support
Marsh & McLennan Companies, Inc.2026-05-21Advisory (Nonbinding) Vote to Approve Named Executive Officer CompensationAgainstFOR — 12 of 22 Equitable fundsAgainstApproved, 88.5% support
Chart Industries, Inc.2025-10-06To approve, by a non-binding advisory vote, certain compensation that may be paid or become payable to Chart's named executive officers that is based on or otherwise relates to the Merger.AgainstFOR — 6 of 9 Equitable fundsAgainstApproved, 95.2% support
International Bancshares Corporation2026-05-18ELECTION OF DIRECTORS: A. R. Sanchez, Jr.ForAGAINST — 6 of 9 Equitable fundsForElected, 85.9% support
Eli Lilly and Company2026-05-04Shareholder Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair.ForAGAINST — 10 of 18 Equitable fundsAgainstNot approved, 33.7% support
Caterpillar, Inc.2026-06-10Shareholder Shareholder Proposal - Shareholder Right to Act by Written ConsentForAGAINST — 11 of 20 Equitable fundsAgainstNot approved, 39.5% support
Lam Research Corporation2025-11-04Shareholder Stockholder proposal titled "Realistic Shareholder Ability to Call for a Special Shareholder Meeting," if properly presented.ForAGAINST — 11 of 20 Equitable fundsAgainst—
Arista Networks, Inc.2026-05-29Election of Directors: Greg LavenderWithholdFOR — 10 of 18 Equitable fundsAgainstElected, 79.1% support
Arista Networks, Inc.2026-05-29Election of Directors: Lewis ChewWithholdFOR — 10 of 18 Equitable fundsAgainstElected, 78.3% support
McDonald's Corporation2026-05-20Shareholder Advisory Vote on Shareholders' Right to Act by Written Consent.ForAGAINST — 11 of 20 Equitable fundsAgainstFailed (calculated), 41.9% support
Analog Devices, Inc.2026-03-11Shareholder To consider a shareholder proposal, if properly presented at the Annual Meeting.ForAGAINST — 10 of 18 Equitable fundsAgainst—
Simon Property Group, Inc.2026-05-13Election of Directors: Daniel C. Smith, Ph.D.AgainstFOR — 11 of 20 Equitable fundsAgainstElected, 95.4% support
Simon Property Group, Inc.2026-05-13Election of Directors: Gary M. RodkinAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 96.3% support
Simon Property Group, Inc.2026-05-13Election of Directors: Glyn F. AeppelAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 87.8% support
Simon Property Group, Inc.2026-05-13Election of Directors: Larry C. GlasscockAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 92.3% support
Simon Property Group, Inc.2026-05-13Election of Directors: Marta R. StewartAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 98.7% support
Simon Property Group, Inc.2026-05-13Election of Directors: Nina P. JonesAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 99.2% support
Simon Property Group, Inc.2026-05-13Election of Directors: Peggy Fang RoeAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 96.6% support
Simon Property Group, Inc.2026-05-13Election of Directors: Randall J. LewisAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 99.2% support
Simon Property Group, Inc.2026-05-13Election of Directors: Reuben S. LeibowitzAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 91.0% support
Simon Property Group, Inc.2026-05-13Election of Directors: Stefan M. SeligAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 98.4% support
Block, Inc.2026-06-16TO ELECT FOUR CLASS II DIRECTORS TO SERVE UNTIL OUR 2029 ANNUAL MEETING OF STOCKHOLDERS AND UNTIL THEIR SUCCESSORS ARE DULY ELECTED AND QUALIFIED: JAMES MCKELVEYWithholdFOR — 10 of 18 Equitable fundsAgainstElected, 93.8% support
Block, Inc.2026-06-16TO ELECT FOUR CLASS II DIRECTORS TO SERVE UNTIL OUR 2029 ANNUAL MEETING OF STOCKHOLDERS AND UNTIL THEIR SUCCESSORS ARE DULY ELECTED AND QUALIFIED: SHAWN CARTERWithholdFOR — 10 of 18 Equitable fundsAgainstElected, 92.4% support
Rockwell Automation, Inc.2026-02-10To elect as directors of Rockwell Automation, Inc. the nominees listed below: Pam MurphyWithholdFOR — 11 of 20 Equitable fundsAgainstElected, 91.6% support
Rockwell Automation, Inc.2026-02-10To elect as directors of Rockwell Automation, Inc. the nominees listed below: Robert W. SoderberyWithholdFOR — 11 of 20 Equitable fundsAgainstElected, 95.4% support
GE Healthcare Technologies, Inc.2026-05-07Election of Directors: Kevin A. LoboAgainstFOR — 10 of 18 Equitable fundsAgainstPassed (calculated), 91.2% support
The Hershey Company2026-05-05Election of Directors: Barry J. NalebuffAgainstFOR — 10 of 18 Equitable fundsAgainstPassed (calculated), 99.8% support
The Hershey Company2026-05-05Election of Directors: Cordel Robbin-CokerAgainstFOR — 10 of 18 Equitable fundsAgainstPassed (calculated), 99.6% support
The Hershey Company2026-05-05Election of Directors: Kevin M. OzanAgainstFOR — 10 of 18 Equitable fundsAgainstPassed (calculated), 99.8% support
The Hershey Company2026-05-05Election of Directors: Marie Quintero-JohnsonAgainstFOR — 10 of 18 Equitable fundsAgainstPassed (calculated), 99.8% support
First Solar, Inc.2026-05-13Shareholder Stockholder proposal to improve shareholder ability to call for a special shareholder meetingForAGAINST — 10 of 18 Equitable fundsAgainstNot approved, 43.2% support
Fidelity National Information Services, Inc.2026-06-10To approve, on an advisory basis, the compensation of the Company's named executive officers.AgainstFOR — 10 of 18 Equitable fundsAgainstApproved, 70.6% support
Paycom Software, Inc.2026-05-04To elect two Class I directors, each to serve until the date of the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or his or her earlier death, resignation or removal: J.C. Watts, Jr.AgainstFOR — 10 of 18 Equitable fundsAgainstPassed (calculated), 74.2% support
Paycom Software, Inc.2026-05-04To elect two Class I directors, each to serve until the date of the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or his or her earlier death, resignation or removal: Sharen J. TurneyAgainstFOR — 10 of 18 Equitable fundsAgainstPassed (calculated), 63.5% support
Domino's Pizza, Inc.2026-04-21Shareholder Shareholder proposal regarding an independent board chair requirement.ForAGAINST — 11 of 20 Equitable fundsAgainstNot approved, 39.9% support
Henry Schein, Inc.2026-05-21Election of Incumbent Directors: Max LinForAGAINST — 10 of 18 Equitable fundsForPassed (calculated), 77.3% support
Hologic, Inc.2026-02-05A proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the transactions contemplated by the merger agreement, including consummation of the merger.ForAGAINST — 10 of 18 Equitable fundsFor—
Alphabet Inc.2026-06-05Election of ten directors: John L. HennessyAgainstFOR — 13 of 25 Equitable fundsAgainstElected, 85.2% support
Berkshire Hathaway Inc.2026-05-02Election of Directors: Ajit JainWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 98.9% support
Berkshire Hathaway Inc.2026-05-02Election of Directors: Christopher C. DavisWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 97.9% support
Berkshire Hathaway Inc.2026-05-02Election of Directors: Gregory E. AbelWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 99.2% support
Berkshire Hathaway Inc.2026-05-02Election of Directors: Howard G. BuffettWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 98.3% support
Berkshire Hathaway Inc.2026-05-02Election of Directors: Meryl B. WitmerWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 98.2% support
Berkshire Hathaway Inc.2026-05-02Election of Directors: Susan A. BuffettWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 98.1% support
Berkshire Hathaway Inc.2026-05-02Election of Directors: Wallace R. WeitzWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 98.7% support
Berkshire Hathaway Inc.2026-05-02Election of Directors: Warren E. BuffettWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 97.6% support
Palantir Technologies Inc.2026-06-03Election of Directors: Alexander KarpWithholdFOR — 9 of 16 Equitable fundsAgainstElected, 93.1% support
Palantir Technologies Inc.2026-06-03Election of Directors: Alexander MooreWithholdFOR — 9 of 16 Equitable fundsAgainstElected, 85.5% support
Palantir Technologies Inc.2026-06-03Election of Directors: Alexandra SchiffWithholdFOR — 9 of 16 Equitable fundsAgainstElected, 86.1% support
Palantir Technologies Inc.2026-06-03Election of Directors: Eric WoerschingWithholdFOR — 9 of 16 Equitable fundsAgainstElected, 99.3% support
Palantir Technologies Inc.2026-06-03Election of Directors: Lauren Friedman StatWithholdFOR — 9 of 16 Equitable fundsAgainstElected, 99.2% support
Palantir Technologies Inc.2026-06-03Election of Directors: Stephen CohenWithholdFOR — 9 of 16 Equitable fundsAgainstElected, 93.0% support
T-Mobile US, Inc.2026-06-16Election of Directors: Thorsten LangheimWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 89.8% support

627 more in the CSV.

Download all 1,127 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 97.3% of this fund’s 15,797 such votes could be given a sector; the other 433 (2.7%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Consumer Discretionary3,1251203.8%
Finance2,913461.6%
Industrials2,226582.6%
Health Care1,994442.2%
Technology1,932864.5%
Real Estate1,02540.4%
Utilities718182.5%
Energy57171.2%
Consumer Staples412225.3%
Telecommunications224104.5%
Basic Materials12110.8%
Miscellaneous10300.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections11,29811
Say-on-Pay1,5400
Audit-related1,4770
Corporate Governance570208
Compensation50011
Capital Structure1700
Extraordinary Transactions1161
Environment or Climate7676
Other Social Issues6562
Shareholder Rights and Defenses5721

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Apple Inc.February 24, 2026$616M121
Microsoft CorporationDecember 5, 2025$474M215
NVIDIA CorporationJune 24, 2026$429M164
Meta Platforms, Inc.May 27, 2026$321M229
Amazon.com, Inc.May 20, 2026$292M174
Alphabet Inc.June 5, 2026$193M2310
Broadcom Inc.April 20, 2026$183M100
Eli Lilly and CompanyMay 4, 2026$136M102

Notable votes against management

MeetingCompanyProposalFundMgmt
February 24, 2026Apple Inc.A shareholder proposal entitled "China Entanglement Audit" Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposalForAgainst
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding report on Al data usage oversight. Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalForAgainst
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposalAgainstFor
June 5, 2026Alphabet Inc.Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposalForAgainst
June 5, 2026Alphabet Inc.Shareholder proposal regarding a report on water usage and AI development Shareholder proposalAgainstFor
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalForAgainst

Contested meetings

Meetings with a proxy contest or competing nominees (5 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

15,898 ballot items at 1,550 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, EQ/Common Stock Index Portfolio voted at 1,550 shareholder meetings of 1,485 companies, on 15,898 ballot items in all. Where management made a recommendation, the fund followed it on 97.0% of the items and voted against it 417 times. Its most frequent area of disagreement was corporate governance (208 of its votes against management). It voted FOR 39.8% of the 417 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than Equitable's funds as a whole (87.8% against 92.5%). It voted differently from most Equitable funds on 1,127 items. 5 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Equitable’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.